Central Line-Associated Bloodstream Infection QI Project

Starting soon

Conditions studied: Central Line-associated Bloodstream Infection (CLABSI)

In brief

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Key facts

Study ID

NCT07746674

Run by

NYU Langone Health

People needed

30

Starts

2026-09-01

Expected to finish

2027-03-01

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Not hospice patient class
• Active central line for at least 24 hours

You may not qualify if…

• No active central line
• Central line present for less than 24 hours

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.